dc.contributor | Departament de Salut |
dc.contributor.author | Sanvisens, Arantza |
dc.contributor.author | Rivas, Inmaculada |
dc.contributor.author | Faure, Eva |
dc.contributor.author | Espinach Garcia, Nestor |
dc.contributor.author | Hernandez-Rubio, Anna |
dc.contributor.author | Majó-Roca, Xavier |
dc.contributor.author | Colom-Farran, Joan |
dc.contributor.author | Muga, Robert |
dc.date.accessioned | 2022-02-07T12:12:03Z |
dc.date.available | 2022-02-07T12:12:03Z |
dc.date.issued | 2020-10-14 |
dc.identifier.citation | Sanvisens A, Rivas I, Faure E, Espinach N, Hernandez-Rubio, A, Majó X, et al. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study. World J Gastroenterol. 2020 Oct 14;26(38):5874-5883. |
dc.identifier.issn | 1007-9327 |
dc.identifier.uri | https://hdl.handle.net/11351/6983 |
dc.description | Agents antivirals d'acció directa; Programa de tractament amb opioides; Teràpia amb agonistes opioides; Infecció pel virus de l'hepatitis C; Infecció pel virus de la immunodeficiència humana; Ús de drogues |
dc.description.sponsorship | Supported by the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain (No. RD16/0017/0003, PI17/00174, INT19/00026, CD19/00019); the Ministry of Health, National Plan on Drugs (PNSD), Spain (No. 2018/020); the European Commission (806996- JUSTSO-JUST2017-AG-DRUG); the Gilead Fellowship Program, Gilead Sciences (No. GLD17/187); the Ministry of Education, Spain (No. PRX18/00245); the Agency for Management of University and Research Grants, Government of Catalonia (No. 2017SGR316); and the Municipal Institute of Personal Services-IMSP, Badalona. |
dc.language.iso | eng |
dc.publisher | Baishideng Publishing Group |
dc.relation.ispartofseries | World journal of gastroenterology;26(38) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Infeccions per VIH - Tractament |
dc.subject | Virus de l'hepatitis C - Tractament |
dc.subject | Opiacis - Ús terapèutic |
dc.subject.mesh | HIV Infections |
dc.subject.mesh | Opiate Substitution Treatment |
dc.subject.mesh | Hepatitis C |
dc.title | Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3748/wjg.v26.i38.5874 |
dc.subject.decs | infecciones por VIH |
dc.subject.decs | tratamiento de sustitución de opiaceos |
dc.subject.decs | hepatitis C |
dc.relation.publishversion | http://dx.doi.org/10.3748/wjg.v26.i38.5874 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Sanvisens A] Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. [Rivas I, Faure E, Espinach N] Mental Health and Addiction Service, Badalona Serveis Assistencials-BSA, Badalona, Spain. [Hernandez-Rubio A, Muga R] Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. [Majó X, Colom J] Programa de Prevenció, Control i Atenció al VIH, les MTS i les Hepatitis Víriques, Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain |
dc.identifier.pmid | 33132641 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |